Literature DB >> 9039883

Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery.

E Bennett-Guerrero1, L Ayuso, C Hamilton-Davies, W D White, G R Barclay, P K Smith, S A King, L H Muhlbaier, M F Newman, M G Mythen.   

Abstract

OBJECTIVE: To test the hypothesis that low serum antiendotoxin core antibody (EndoCAb) level is an independent predictor of adverse outcome following cardiac surgery.
DESIGN: Prospective, blinded, cohort study.
SETTING: Tertiary care medical center.
SUBJECTS: A total of 301 patients undergoing coronary artery bypass graft surgery and/or valvular heart surgery.
DESIGN: Preoperative serum was assayed for IgM EndoCAb, IgG EndoCAb, total IgM, and total IgG levels. Known preoperative risk factors were assessed, and patients were assigned a risk score using a validated method. MAIN OUTCOME MEASURE: A major complication, defined as either in-hospital death or postoperative length of stay greater than 10 days.
RESULTS: Overall, a major complication occurred in 34 patients (11.3%). Lower IgM EndoCAb level independently predicted (P=.002) increased risk of major complication over and above the effects of preoperative risk score (P=.02), total IgG level (P=.07), and all other known perioperative risk factors. In contrast, IgG Endo-CAb and total IgM concentrations did not predict outcome. No association existed between risk score and level of IgM EndoCAb.
CONCLUSION: There is marked preoperative variability in humoral immunity against endotoxin core, which is not accounted for by differences in known preoperative risk factors. In this study, low levels of IgMEndoCAb were an important independent predictor of adverse postoperative outcome, which supports the theory that endotoxemia is a cause of postoperative morbidity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039883

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

1.  Non-invasive markers of gut wall integrity in health and disease.

Authors:  Joep P M Derikx; Misha D P Luyer; Erik Heineman; Wim A Buurman
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Non-invasive assessment of barrier integrity and function of the human gut.

Authors:  Joep Grootjans; Geertje Thuijls; Froukje Verdam; Joep Pm Derikx; Kaatje Lenaerts; Wim A Buurman
Journal:  World J Gastrointest Surg       Date:  2010-03-27

3.  Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis.

Authors:  Jing Hou; Ming-Wei Zhu; Xiu-Wen He; Jun-Ming Wei; Yong-Guo Li; Da-nian Tang
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

4.  Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?

Authors:  Joseph A Carcillo
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

Review 5.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

Authors:  R G Holzheimer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

6.  Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children.

Authors:  R C M Stephens; K Fidler; P Wilson; G R Barclay; M G Mythen; G L J Dixon; M W Turner; N J Klein; M J Peters
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

7.  Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.

Authors:  E Bennett-Guerrero; T J McIntosh; G R Barclay; D S Snyder; R J Gibbs; M G Mythen; I R Poxton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 9.  Advances in sepsis therapy.

Authors:  Thomas Glück; Steven M Opal
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Gastric hypercarbia and adverse outcome after cardiac surgery.

Authors:  Minoo N Kavarana; Robert J Frumento; Andrew L Hirsch; Mehmet C Oz; Daniel C Lee; Elliott Bennett-Guerrero
Journal:  Intensive Care Med       Date:  2003-04-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.